FindTrial
Sign In

E-Cadherin Expression Among Lesional And Normal Skin Of Non-Segmental Vitiligo Patients

Study Of E-Cadherin Expression Among Lesional And Normal Skin Of Non-Segmental Vitiligo Patients A Facility Based Cross Sectional Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/104030
Enrollment
42
Registered
2026-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Nil: Nil

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with non-segmental vitiligo

Exclusion criteria

Exclusion criteria: 1. Patients with only mucosal vitiligo lesion. 2. Patients with segmental vitiligo. 3. Patients younger than 18 yrs of age. 4. Patients not providing consent for the study. 5. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
1. Difference in E-cadherin expression across lesional and normal skin in non- segmental vitiligo, quantified by an IHC metric (e.g. H score, % of positive cells, membranous staining intensity, Distribution, Cellular pattern and Localization). 2. Association of E-cadherin expression with clinical variables such as duration of disease, extent of vitiligo, disease activity. Timepoint: at baseline—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactRojalin Mallick

All India Institute of Medical Sciences, Gorakhpur

shivangi.rana356@gmail.com8860565443

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026